TheTechno Optimist.

OvoPro animal-free egg proteinThe EVERY Company—The EVERY Company partners with Huvepharma to quadruple OvoPro production capacityOvoPro animal-free egg proteinThe EVERY Company—ADM and The EVERY Company partner to produce OvoPro at commercial scale in IowaOvoPro animal-free egg proteinThe EVERY Company—OvoPro orders surge 550% in four months; national placement secured in Target and WalmartThe EVERY Company—The EVERY Company raises $55M Series D from McWin Capital Partners and co-investors

The EVERY Company

Precision fermentation, animal-free egg proteins

USprivate~181 staffest. 2014every.com (opens every.com)Checked 10 Oct

The brief

Analyst view
  • Raised $308.75M (14 rounds); Series D: $55M from McWin Capital, Bloom8, SOSV.
  • Orders surged 550% in 4 months; Huvepharma partnership 4x capacity.
  • Placed in Target and Walmart; used in frozen foods and baked goods.

Technical approach

As reported
Precision fermentation

Genetically programmed microbes

The company uses engineered microorganisms that produce ovalbumin protein, the functional ingredient in egg white, through fermentation rather than chickens.

Drop-in replacement

Functional match to conventional eggs

OvoPro replicates the binding, foaming, gelling and whipping properties of conventional eggs, allowing food makers to use it without reformulation.

Supply chain resilience

Decoupled from animal agriculture

Fermentation-based production is independent of weather, disease and animal cycles, offering consistent supply and pricing.

Primer